An electronic newsletter from PATH’s vaccine development program

Vaccines for the Future provides a periodic update on PATH’s efforts to develop new, appropriate, and affordable vaccines against two leading causes of death in developing-world populations: pneumonia and diarrhea. It includes updates on our progress, partnerships, and specific projects related to vaccines against pneumococcal disease, rotavirus, Shigella, enterotoxigenic E. coli (ETEC), and influenza.

Sign up for Vaccines for the Future with a message to pvs@path.org.

Click on the links below to access past issues.

April 2008

  • New research agreement to develop temperature stable enteric vaccine formulations
  • New collaborations for pneumococcal vaccine development
  • Moving toward increased protection against influenza

January 2008

  • Developing new vaccines against influenza
  • Rotavirus vaccine trial completes enrollment
  • New genome data on developing-world pneumococcal strains
  • Moving toward vaccines against bacterial causes of diarrhea

October 2007

  • Developing new vaccines against diarrheal disease
  • Ramping up against rotavirus
  • Expanding protection against pneumonia
  • Assessing influenza vaccine needs